Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2178222 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| SCHEMBL28463865 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| SCHEMBL28501051 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| SCHEMBL28415458 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| Ammonia Solution, Strong SCHEMBL5048410 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| SCHEMBL28564581 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| SCHEMBL9387459 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| SCHEMBL2971627 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| SCHEMBL20521418 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 | |
| SCHEMBL7125983 | 0.98 | CYP2D6 (0.35) | CYP2C19HIF1ACYP2D6TSHRCPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106608912-A | Aliphatic-dicarboxylic-acid-coupled EPO mimic peptide derivative and preparation method and application thereof | 天津药物研究院有限公司 | 2017-05-03 | — | — | CN | claimed |
| US-7319032-B2 | Non-sugar sweeteners for use in test devices | MEDTOX (US) | 2008-01-15 | — | — | US | claimed |
| EP-1833298-A1 | STABLE CONCENTRATED ANTI-BACTERIAL EMULSIONS OF MONOCAPRIN IN WATER | Thormar, Halldor (IS) | 2007-09-19 | — | — | EP | claimed |
| WO-2006064520-A9 | STABLE CONCENTRATED ANTI-BACTERIAL EMULSIONS OF MONOCAPRIN IN WATER | THORMAR HALLDOR (IS) | 2006-11-16 | — | — | WO | claimed |
| WO-2006064520-A1 | STABLE CONCENTRATED ANTI-BACTERIAL EMULSIONS OF MONOCAPRIN IN WATER | THORMAR HALLDOR (IS) | 2006-06-22 | — | — | WO | claimed |
| CN-106632133-B | Thiazole derivative and the preparation method and application thereof | 山东大学 | 2019-04-16 | — | — | CN | disclosed |
| WO-2017165956-A1 | METABOLOMICS ANALYSIS OF RENAL CELL CARCINOMA | UTI LIMITED PARTNERSHIP (CA) | 2017-10-05 | — | — | WO | disclosed |
| US-9765294-B2 | Chemically defined medium for the industrial scale culture of a species of Bordetella | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2017-09-19 | — | — | US | disclosed |
| EP-3044308-B1 | A CHEMICALLY DEFINED MEDIUM FOR THE INDUSTRIAL SCALE CULTURE OF A SPECIES OF BORDETELLA | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2017-08-09 | — | — | EP | disclosed |
| CN-106632133-A | Novel thiazole derivatives, and preparation method and application thereof | 山东大学 | 2017-05-10 | — | — | CN | disclosed |
| CN-106608913-A | 1,2,3-tricarballylic acid coupled EPO peptoid derivative and preparation method and application thereof | 天津药物研究院有限公司 | 2017-05-03 | — | — | CN | disclosed |
| CN-106554394-A | A kind of Erythropoietin mimetic peptide and its preparation method and application | 天津药物研究院有限公司 | 2017-04-05 | — | — | CN | disclosed |
| WO-2004105710-A1 | TRANSPARENT CONDITIONING SHAMPOO | COLGATE-PALMOLIVE COMPANY (US) | 2004-12-09 | — | — | WO | disclosed |
| US-6743760-B1 | ANIONIC SURFACTANT; SILICONE QUATERNIUM-8; LOW MOLECULAR WEIGHT GUAR GUM; POLYQUATERNIUM-10; AMPHOTERIC SURFACTANT | COLGATE-PALMOLIVE COMPANY | 2004-06-01 | — | — | US | disclosed |
| EP-1328165-A2 | CALCIUM-SUPPLEMENTED BEVERAGES AND METHOD OF MAKING SAME | PepsiCo, Inc. (US) | 2003-07-23 | — | — | EP | disclosed |
| US-20020102331-A1 | Calcium-supplemented beverages and method of making same | PEPSICO, INC. | 2002-08-01 | — | — | US | disclosed |
| WO-2002032236-A2 | CALCIUM-SUPPLEMENTED BEVERAGES AND METHOD OF MAKING SAME | PEPSICO, INC. (US) | 2002-04-25 | — | — | WO | disclosed |
| US-5514802-A | Intermediates for preparing HIV protease inhibitors | ELI LILLY AND COMPANY (US) | 1996-05-07 | — | — | US | disclosed |
| US-5240957-A | Dopaminergic agent | ASTRA LAKEMEDEL AKTEIBOLAG (SE) | 1993-08-31 | — | — | US | disclosed |
| EP-0049618-B1 | IMPROVEMENTS IN OR RELATING TO 2,4-DISUBSTITUTED THIAZOLE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1985-08-14 | — | — | EP | disclosed |